TriSalus Life Sciences Long Term Debt

TriSalus Life Sciences (TLSI) currently reports a long-term debt of $34M as of June 2026. That compares with $34M in the prior-year period — up 1.9% year over year. Use the charts on this page to explore TriSalus Life Sciences's long-term debt history and peer comparisons.

TriSalus Life Sciences's long-term debt increased from $34M to $34M — a 1.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

TriSalus Life Sciences reported $34M in long-term debt as of June 2026. That compares with $34M in the prior-year period — up 1.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $34M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for TriSalus Life Sciences, and consider following TLSI for alerts when major investors trade the stock.